ES2121841T3 - Una vacuna para proporcionar proteccion inmunologica contra enfermedades de rotavirus en humanos. - Google Patents

Una vacuna para proporcionar proteccion inmunologica contra enfermedades de rotavirus en humanos.

Info

Publication number
ES2121841T3
ES2121841T3 ES92900590T ES92900590T ES2121841T3 ES 2121841 T3 ES2121841 T3 ES 2121841T3 ES 92900590 T ES92900590 T ES 92900590T ES 92900590 T ES92900590 T ES 92900590T ES 2121841 T3 ES2121841 T3 ES 2121841T3
Authority
ES
Spain
Prior art keywords
hrv
human
novel
rotaviruses
vaccine
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES92900590T
Other languages
English (en)
Inventor
Richard L Ward
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Cincinnati Childrens Hospital Medical Center
Original Assignee
Cincinnati Childrens Hospital Medical Center
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Cincinnati Childrens Hospital Medical Center filed Critical Cincinnati Childrens Hospital Medical Center
Application granted granted Critical
Publication of ES2121841T3 publication Critical patent/ES2121841T3/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/12—Viral antigens
    • A61K39/15—Reoviridae, e.g. calf diarrhea virus
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/12—Viral antigens
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N7/00—Viruses; Bacteriophages; Compositions thereof; Preparation or purification thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/57—Medicinal preparations containing antigens or antibodies characterised by the type of response, e.g. Th1, Th2
    • A61K2039/575—Medicinal preparations containing antigens or antibodies characterised by the type of response, e.g. Th1, Th2 humoral response
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2720/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsRNA viruses
    • C12N2720/00011—Details
    • C12N2720/12011—Reoviridae
    • C12N2720/12311—Rotavirus, e.g. rotavirus A
    • C12N2720/12321—Viruses as such, e.g. new isolates, mutants or their genomic sequences
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2720/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsRNA viruses
    • C12N2720/00011—Details
    • C12N2720/12011—Reoviridae
    • C12N2720/12311—Rotavirus, e.g. rotavirus A
    • C12N2720/12334—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Virology (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Immunology (AREA)
  • Microbiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Organic Chemistry (AREA)
  • Epidemiology (AREA)
  • Zoology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Mycology (AREA)
  • Genetics & Genomics (AREA)
  • Wood Science & Technology (AREA)
  • Biomedical Technology (AREA)
  • Biochemistry (AREA)
  • General Engineering & Computer Science (AREA)
  • Biotechnology (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Peptides Or Proteins (AREA)
  • Medicinal Preparation (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)

Abstract

SE PRESENTAN NUEVOS RETROVIRUS HUMANOS AISLADOS. LOS NUEVOS RETROVIRUS HUMANOS DE ACUERDO CON LA INVENCION TIENEN DERIVADOS SUS SEGMENTOS GENOMICOS A PARTIR DE LAS RAMAS PARENTERALES DE GENOGRUPOS Y/O SEROTIPOS. LOS RETROVIRUS DE LA INVENCION SE DESIGNAN COMO HRV 248, HRV 456, HRV 89-12C2, HRV 408 Y CJN. LOS RETROVIRUS DESIGNADOS COMO HRV 89-12C2, HRV 408, HRV 248 Y CJN HAN SIDO DEPOSITADOS CON LA "AMERICAN TYPE CULTURE COLLECTION" (ATCC), 12301 PARKLAWN DRIVE, ROCKVILLE, MD 20852, Y HAN SIDO ASIGNADOS A LOS SIGUIENTES NUMEROS DE LA ATCC VR 2272, VR 2273, VR 2274 Y VR 2275, RESPECTIVAMENTE. TAMBIEN SE HAN DESCUBIERTO NUEVAS VACUNAS FORMULADAS CON LOS RETROVIRUS HUMANOS DE LA INVENCION, Y METODOS DE VACUNACION DE LOS HUMANOS CONTRA LOS RETROVIRUS HUMANOS DE SEROTIPOS MULTIPLES CON TALES VACUNAS. TAMBIEN SE HA DESCUBIERTO UN NUEVO METODO DE NEUTRALIZACION DE ANTICUERPOS Y DE EXPANSION DE LA MEMORIA DE LAS CELULAS GENERADAS QUE EXPRESAN EL ANTICUERPO NEUTRALIZANTE FORMADO DESPUES DE LA VACUNACION PRIMARIA PARA EVITAR LAS ENFERMEDADES INDUCIDAS POR RETROVIRUS HUMANOS DE TODOS LOS SEROTIPOS, EL METODO COMPRENDE LA REVACUNACION DE LOS SUJETOS CON UNA VACUNA DE RETROVIRUS HETEROTIPICO ANIMAL NO HUMANO, TAL COMO CON UNA VACUNA DE WC3 BOBINO.
ES92900590T 1990-11-16 1991-11-04 Una vacuna para proporcionar proteccion inmunologica contra enfermedades de rotavirus en humanos. Expired - Lifetime ES2121841T3 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US61431090A 1990-11-16 1990-11-16

Publications (1)

Publication Number Publication Date
ES2121841T3 true ES2121841T3 (es) 1998-12-16

Family

ID=24460695

Family Applications (1)

Application Number Title Priority Date Filing Date
ES92900590T Expired - Lifetime ES2121841T3 (es) 1990-11-16 1991-11-04 Una vacuna para proporcionar proteccion inmunologica contra enfermedades de rotavirus en humanos.

Country Status (13)

Country Link
US (2) US5474773A (es)
EP (1) EP0557427B1 (es)
JP (1) JP2753393B2 (es)
KR (1) KR0171434B1 (es)
AT (1) ATE170081T1 (es)
AU (2) AU9060391A (es)
BR (1) BR9106982A (es)
CA (1) CA2096315C (es)
DE (1) DE69130068T2 (es)
DK (1) DK0557427T3 (es)
ES (1) ES2121841T3 (es)
GR (1) GR3027744T3 (es)
WO (1) WO1992008786A1 (es)

Families Citing this family (22)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5626851A (en) * 1987-11-30 1997-05-06 The Wistar Institute Of Anatomy And Biology Rotavirus reassortant vaccine
US5610049A (en) * 1991-05-01 1997-03-11 The Wistar Institute Of Anatomy And Biology Human rotavirus HCR3A and method of growing said rotavirus
US6780630B1 (en) * 1992-07-10 2004-08-24 Baylor College Of Medicine Parenteral immunization against rotavirus
US5773009A (en) * 1994-04-15 1998-06-30 The United States Of America As Represented By The Department Of Health And Human Services Rotavirus strain G9P11
US7150984B2 (en) * 1994-07-11 2006-12-19 The United States Of America As Represented By The Department Of Health And Human Services Attenuated human rotavirus vaccine
US6673355B1 (en) 1995-06-14 2004-01-06 Baylor College Of Medicine Rotavirus enterotoxin NSP4 and methods of using same
AU6387196A (en) 1995-06-14 1997-01-15 Baylor College Of Medicine Rotavirus enterotoxin nsp4 and methods of using same
ID20581A (id) * 1996-10-18 1999-01-21 Res Fnd For Micbial Diseases O Antigen rotavirus, vaksin dan agen diagnostik untuk infeksi rotavirus, serta metode untuk menghasilkan antigen
US6589529B1 (en) 1998-10-30 2003-07-08 Children's Hospital Medical Center Rotavirus subunit vaccine
GB9919468D0 (en) 1999-08-17 1999-10-20 Smithkline Beecham Biolog Vaccine
DZ3219A1 (fr) * 1999-08-17 2001-02-22 Smithkline Beecham Biolog Vaccin
KR100305188B1 (ko) * 2000-12-26 2001-09-24 정동혁 로타바이러스에 대한 백신
NZ545639A (en) * 2003-09-02 2009-04-30 Glaxosmithkline Biolog Sa Cross-protective live attenuated human rotavirus vaccine
GB0414787D0 (en) * 2004-07-01 2004-08-04 Glaxosmithkline Biolog Sa Method
CN100448485C (zh) * 2003-09-02 2009-01-07 葛兰素史密丝克莱恩生物有限公司 疫苗
GB0503337D0 (en) 2005-02-17 2005-03-23 Glaxosmithkline Biolog Sa Compositions
US20090028828A1 (en) * 2005-08-17 2009-01-29 Glaxosmithkline Biologicals Sa Rotavirus Vaccine Inducing Heterotypic Cross Protection
ES2723776T3 (es) 2009-05-12 2019-09-02 The Government Of The Us Secretary Department Of Health And Human Services Nuevas cepas de rotavirus humano y vacunas
EP2847324B1 (en) 2012-05-11 2018-01-03 Medicago Inc. Rotavirus-like particle production in plants
CN107208072A (zh) 2015-01-23 2017-09-26 莫迪卡戈公司 在植物中产生轮状病毒样颗粒
GB201614799D0 (en) 2016-09-01 2016-10-19 Glaxosmithkline Biologicals Sa Compositions
CN117737005B (zh) * 2024-01-31 2024-05-14 金宇保灵生物药品有限公司 一株猪轮状病毒毒株及其应用

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4341870A (en) * 1980-11-19 1982-07-27 The United States Of America As Represented By The Secretary Of The Department Of Health & Human Services Cultivatable human rotavirus type 2
US4341763A (en) * 1981-03-10 1982-07-27 Smithkline-Rit Methods of vaccinating humans against rotavirus infection
US4571385A (en) * 1983-06-27 1986-02-18 The United States Of America As Represented By The Department Of Health And Human Services Genetic reassortment of rotaviruses for production of vaccines and vaccine precursors
US4624850A (en) * 1984-02-09 1986-11-25 Royal Children's Hospital Research Foundation Live attenuated human rotavirus vaccine
US4636385A (en) * 1985-02-15 1987-01-13 The Wistar Institute Of Anatomy & Biology Vaccine, method for its preparation, and use thereof in vaccinating humans against rotavirus infection
US4853333A (en) * 1985-07-26 1989-08-01 American Home Products Corporation Production of rotavirus in yeast
US4751080A (en) * 1985-08-26 1988-06-14 The United States Of America As Represented By The Department Of Health And Human Services Vaccine against rotavirus diseases
US4927628A (en) * 1987-09-21 1990-05-22 The United States Of America As Represented By The Department Of Health And Human Services Vaccine against rotavirus diseases and method of preparing same
WO1989006971A1 (en) * 1988-02-01 1989-08-10 The Board Of Trustees Of The Leland Stanford Junio Conserved rotavirus gene segments and use in immunization and neutralization

Also Published As

Publication number Publication date
KR0171434B1 (ko) 1999-02-01
AU3787795A (en) 1996-02-29
GR3027744T3 (en) 1998-11-30
EP0557427B1 (en) 1998-08-26
DE69130068T2 (de) 1999-01-07
DK0557427T3 (da) 1998-10-26
US5474773A (en) 1995-12-12
CA2096315C (en) 1996-11-19
AU9060391A (en) 1992-06-11
JP2753393B2 (ja) 1998-05-20
AU702044B2 (en) 1999-02-11
BR9106982A (pt) 1993-08-31
US5695767A (en) 1997-12-09
EP0557427A1 (en) 1993-09-01
JPH06505964A (ja) 1994-07-07
EP0557427A4 (es) 1995-01-25
DE69130068D1 (de) 1998-10-01
WO1992008786A1 (en) 1992-05-29
CA2096315A1 (fr) 1992-05-17
ATE170081T1 (de) 1998-09-15

Similar Documents

Publication Publication Date Title
ES2121841T3 (es) Una vacuna para proporcionar proteccion inmunologica contra enfermedades de rotavirus en humanos.
Barnard, BJH & Botha An inactivated rift valley fever vaccine
Offit et al. Rotavirus-specific cytotoxic T lymphocytes passively protect against gastroenteritis in suckling mice
US5462734A (en) Bovine herpesvirus vaccine and method of using same
Fekadu et al. Efficacy of rabies vaccines against Duvenhage virus isolated from European house bats (Eptesicus serotinus), classic rabies and rabies-related viruses
AU597603B2 (en) Eimeria acervulina immunogens
EP0192404A3 (en) Vaccine, method for its preparation and use thereof in vaccinating humans against rotavirus infection
DK0755259T3 (da) Kimære-cDNA-kloner af virussen for den infektiöse GUMBORO-syge, ekspressionsprodukter heraf og vacciner baseret derpå
DK162171B (da) Monoklonale antistoffer, der er reaktive med eimeriaarters sporozoitters antigener, og fremgangsmaade til deres fremstilling
Boone et al. Tumour immunity induced in mice with cell-free homogenates of influenza virus-infected tumour cells
DE2967036D1 (en) Vaccine and method of making
US5610059A (en) Etiological agent for porcine enteritis
FI87530B (fi) Foerfarande foer framstaellning av streptococcus equi -stammen
EP0498804A1 (en) PROCESS FOR THE PREPARATION OF VACCINES OR TOXIC AGENTS AND FOR IMMUNIZATION AGAINST PATHOGENIC DISEASES.
Gao et al. Truncated bovine herpesvirus-1 glycoprotein I (gpI) initiates a protective local immune response in its natural host
IL104382A0 (en) Vaccine containing acemannan as an adjuvant
US3962422A (en) Method for immunizing nursing piglets against transmissible gastroenteritis(TGE) virus
US5110589A (en) Swine dysentery subunit vaccine and method
Nutter Antigens of Pasteurella tularensis: preparative procedures
Ward Human rotaviruses, vaccines and method
Yoo et al. Maternal immunization of pregnant cattle with recombinant VP8* protein of bovine rotavirus elicits neutralizing antibodies to multiple serotypes: colostral neutralizing antibody by rotavirus VP8
US4788059A (en) Equine strangles vaccine and the method of preparing and using the same
Flores et al. Molecular cloning of rotaviral genes: Implications for immunoprophylaxis.
JPH072650B2 (ja) ロタウイルスワクチン
SU546132A1 (ru) Способ профилактики гриппа

Legal Events

Date Code Title Description
FG2A Definitive protection

Ref document number: 557427

Country of ref document: ES